Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Health and economic impacts of Lassa vaccination campaigns in West Africa.
Smith DRM, Turner J, Fahr P, Attfield LA, Bessell PR, Donnelly CA, Gibb R, Jones KE, Redding DW, Asogun D, Ayodeji OO, Azuogu BN, Fischer WA 2nd, Jan K, Olayinka AT, Wohl DA, Torkelson AA, Dinkel KA, Nixon EJ, Pouwels KB, Hollingsworth TD. Smith DRM, et al. Among authors: olayinka at. Nat Med. 2024 Aug 28. doi: 10.1038/s41591-024-03232-y. Online ahead of print. Nat Med. 2024. PMID: 39198710
The West Africa Lassa fever Consortium pre-positioned protocol for a Phase II/III adaptive, randomised, controlled, platform trial to evaluate multiple Lassa fever therapeutics.
Bourner J, Salam AP, Jaspard M, Olayinka A, Fritzell C, Goncalves B, Vaillant M, Edwards T, Erameh C, Ajayi N, Ramharter M, Olliaro P; WALC Work Package 2 Working Group. Bourner J, et al. Wellcome Open Res. 2023 Jun 2;8:122. doi: 10.12688/wellcomeopenres.19041.2. eCollection 2023. Wellcome Open Res. 2023. PMID: 39211525 Free PMC article.
Health and economic impacts of Lassa vaccination campaigns in West Africa.
Smith DRM, Turner J, Fahr P, Attfield LA, Bessell PR, Donnelly CA, Gibb R, Jones KE, Redding DW, Asogun D, Ayodeji OO, Azuogu BN, Fischer WA, Jan K, Olayinka AT, Wohl DA, Torkelson AA, Dinkel KA, Nixon EJ, Pouwels KB, Hollingsworth TD. Smith DRM, et al. Among authors: olayinka at. medRxiv [Preprint]. 2024 Jun 30:2024.02.26.24303394. doi: 10.1101/2024.02.26.24303394. medRxiv. 2024. Update in: Nat Med. 2024 Aug 28. doi: 10.1038/s41591-024-03232-y PMID: 38978680 Free PMC article. Updated. Preprint.
INDOLEAMINE-2,3-DIOXYGENASE GENE EXPRESSION LEVELS IN RESPONSE TO CHRONIC HEPATITIS B VIRUS INFECTION IN ZARIA, NIGERIA.
Ahmad AE, Bakari AG, Musa BOP, Mustapha SK, Yusuf BJ, Abdullahi IN, Tahir MI, Afolaranmi TO, Hawkins C, Sagay AS, Muktar HM, Usman Y, Anka AU, Olayinka AT. Ahmad AE, et al. Among authors: olayinka at. Niger J Immunol. 2023 Sep 7;4(1):https://ojshostng.com/index.php/NJI/article/view/2721. Niger J Immunol. 2023. PMID: 37829172 Free PMC article. No abstract available.
Proteome based analysis of circulating SARS-CoV-2 variants: approach to a universal vaccine candidate.
Oladipo EK, Ojo TO, Olufemi SE, Irewolede BA, Adediran DA, Abiala AG, Hezekiah OS, Idowu AF, Oladeji YG, Ikuomola MO, Olayinka AT, Akanbi GO, Idowu UA, Olubodun OA, Odunlami FD, Ogunniran JA, Akinro OP, Adegoke HM, Folakanmi EO, Usman TA, Oladokun EF, Oluwasanya GJ, Awobiyi HO, Oluwasegun JA, Akintibubo SA, Jimah EM. Oladipo EK, et al. Among authors: olayinka at. Genes Genomics. 2023 Dec;45(12):1489-1508. doi: 10.1007/s13258-023-01426-1. Epub 2023 Aug 7. Genes Genomics. 2023. PMID: 37548884
Analysis of sociodemographic and clinical factors associated with Lassa fever disease and mortality in Nigeria.
Olayinka AT, Elimian K, Ipadeola O, Dan-Nwafor C, Gibson J, Ochu C, Furuse Y, Iniobong A, Akano A, Enenche L, Onoja M, Uzoho C, Ugbogulu N, Makava F, Arinze C, Namara G, Muwanguzi E, Jan K, Ukponu W, Okwor T, Anueyiagu C, Saleh M, Ahumibe A, Eneh C, Ilori E, Mba N, Ihekweazu C. Olayinka AT, et al. PLOS Glob Public Health. 2022 Aug 26;2(8):e0000191. doi: 10.1371/journal.pgph.0000191. eCollection 2022. PLOS Glob Public Health. 2022. PMID: 36962735 Free PMC article.
Bioinformatics analysis of structural protein to approach a vaccine candidate against Vibrio cholerae infection.
Oladipo EK, Akindiya OE, Oluwasanya GJ, Akanbi GM, Olufemi SE, Adediran DA, Bamigboye FO, Aremu RO, Kolapo KT, Oluwasegun JA, Awobiyi HO, Jimah EM, Irewolede BA, Folakanmi EO, Olubodun OA, Akintibubo SA, Odunlami FD, Ojo TO, Akinro OP, Hezikiah OS, Olayinka AT, Abiala GA, Idowu AF, Ogunniran JA, Ikuomola MO, Adegoke HM, Idowu UA, Olaniyan OP, Bamigboye OO, Akinde SB, Babalola MO. Oladipo EK, et al. Among authors: olayinka at. Immunogenetics. 2023 Apr;75(2):99-114. doi: 10.1007/s00251-022-01282-5. Epub 2022 Dec 2. Immunogenetics. 2023. PMID: 36459183 Free PMC article.
Immunoinformatics design of multi-epitope peptide for the diagnosis of Schistosoma haematobium infection.
Oladipo EK, Jimah EM, Irewolede BA, Folakanmi EO, Olubodun OA, Adediran DA, Akintibubo SA, Odunlami FD, Olufemi SE, Ojo TO, Akinro OP, Hezekiah OS, Olayinka AT, Abiala GA, Idowu AF, Ogunniran JA, Ikuomola MO, Adegoke HM, Idowu UA, Akindiya OE, Oluwasanya GJ, Akanbi GM, Bamigboye FO, Aremu RO, Awobiyi HO, Kolapo KT, Oluwasegun JA, Olatunde SK, Adelusi TI. Oladipo EK, et al. Among authors: olayinka at. J Biomol Struct Dyn. 2023 Aug-Sep;41(14):6676-6683. doi: 10.1080/07391102.2022.2111358. Epub 2022 Aug 13. J Biomol Struct Dyn. 2023. PMID: 35968636
A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever.
Olayinka AT, Bourner J, Akpede GO, Okoeguale J, Abejegah C, Ajayi NA, Akude C, Ayodeji O, Bausch DG, de Clerck H, Dan-Nwafor C, Dunning J, Erameh C, Eze JN, Formenty P, Gillesen A, Jalloh S, Jaspard M, Jegede T, Maikere J, Malvy D, Ogbaini-Emovon E, Ojo OE, Okogbenin S, O'Neill K, Orji ML, Owhin SO, Ramharter M, Samuels RJ, Shehu N, Merson L, Salam AP, Kayem ND, Horby P, Ihekweazu C, Olliaro P. Olayinka AT, et al. PLoS Negl Trop Dis. 2022 Jan 6;16(1):e0010089. doi: 10.1371/journal.pntd.0010089. eCollection 2022 Jan. PLoS Negl Trop Dis. 2022. PMID: 34990453 Free PMC article.
34 results